Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Epstein

Showing results (1291-1300 of 1,320) with videos related to

Pageof 132
Sort By:
Plos One|October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsMartha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.
Lancet (London, England)|January 18, 2011
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesMuredach P Reilly, Mingyao Li, Jing He, et al.
Plos One|October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP componentCindy Tamminga, Martha Sedegah, David Regis, et al.
Circulation. Cardiovascular Genetics|October 7, 2010
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controlsMichael Preuss, Inke R König, John R Thompson, et al.
Plos One|September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adultsMarvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.
Human Vaccines & Immunotherapeutics|November 16, 2012
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAThomas L Richie, Yupin Charoenvit, Ruobing Wang, et al.
Plos One|March 5, 2013
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunityIlin Chuang, Martha Sedegah, Susan Cicatelli, et al.
JCI Insight|January 19, 2017
Protection against <i>Plasmodium falciparum</i> malaria by PfSPZ VaccineJudith E Epstein, Kristopher M Paolino, Thomas L Richie, et al.
Science (New York, N.Y.)|August 10, 2013
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccineRobert A Seder, Lee-Jah Chang, Mary E Enama, et al.
Pageof 132

Showing results (1291-1300 of 1,320) with videos related to

Sort By:
Pageof 132
Plos One|October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsMartha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
Science (New York, N.Y.)|September 10, 2011
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.
Lancet (London, England)|January 18, 2011
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesMuredach P Reilly, Mingyao Li, Jing He, et al.
Plos One|October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP componentCindy Tamminga, Martha Sedegah, David Regis, et al.
Circulation. Cardiovascular Genetics|October 7, 2010
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controlsMichael Preuss, Inke R König, John R Thompson, et al.
Plos One|September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adultsMarvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.
Human Vaccines & Immunotherapeutics|November 16, 2012
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAThomas L Richie, Yupin Charoenvit, Ruobing Wang, et al.
Plos One|March 5, 2013
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunityIlin Chuang, Martha Sedegah, Susan Cicatelli, et al.
JCI Insight|January 19, 2017
Protection against <i>Plasmodium falciparum</i> malaria by PfSPZ VaccineJudith E Epstein, Kristopher M Paolino, Thomas L Richie, et al.
Science (New York, N.Y.)|August 10, 2013
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccineRobert A Seder, Lee-Jah Chang, Mary E Enama, et al.
Pageof 132